JEREMY CLARK: Open Payments
NPI 1003334665 · BESSEMER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 36 payments from 8 companies in 2025. Trend: 2023 $768 · 2024 $516 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $204 |
| PFIZER INC. | 8 | $159 |
| ABBVIE INC. | 11 | $139 |
| Madrigal Pharmaceuticals | 4 | $115 |
| Celltrion USA Inc. | 3 | $61 |
| QOL Medical, LLC | 2 | $51 |
| Novo Nordisk Inc | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
Products named: IBSRELA, XELJANZ, REZDIFFRA, RINVOQ, VEGZELMA, Sucraid, Wegovy, CREON.
Industry payments across AL — which companies pay providers there.
